HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $1.77M invested in Hepion Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.4K | |
| 2 | +$9.83K | |
| 3 | +$747 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$455 |
| 5 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
+$438 |
Top Sellers
| 1 | -$69.7K | |
| 2 | -$41K | |
| 3 | -$7.47K | |
| 4 |
Morgan Stanley
New York
|
-$3.88K |
| 5 |
JPMorgan Chase & Co
New York
|
-$3.61K |